Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Altis Labs is a computational imaging company that leverages artificial intelligence to accelerate the development of life-saving therapies. The company's proprietary platform, Nota, enables biopharmaceutical partners to analyze medical imaging data from clinical trials to better predict patient outcomes and treatment response. By utilizing a vast database of longitudinal clinical data and advanced deep learning models, Altis provides prognostic and predictive biomarkers that enhance trial efficiency and reduce R&D risk. The company primarily focuses on oncology but is expanding its capabilities into other therapeutic areas where imaging is a critical endpoint. Altis works closely with global pharmaceutical companies and leading medical institutions to integrate AI-powered insights into the drug development lifecycle.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Altis Labs.